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Within pharmaceutical preformulation development, we are interested in information 
which is helpful for drug product formulation. The properties expected from drug 
product are stability and suitability for manufacturing. All of these properties must be 
in accordance with therapeutic and regulatory requirements. For this purpose, there 
are many analytical methods used in the pharmaceutical industry that serve for 
investigation of stability, quality and possible interactions of active pharmaceutical 
ingredient with excipients. Accuracy, efficacy, and especially promptness and 
difficultness of analysis are the criteria for selection of a particular analytical method. 
Solid state methods are essential, just for their smart use and applicability to acquiring 
further characteristics of the sample, e.g. polymorphisms, size and particles 
distribution, which represent crucial knowledge, for formulation of final drug product 
and its properties. 
A survey at thedevelopment department in laboratories of solid state, Zentiva, k.s., 
was performed using the infrared and Raman spectroscopy focused on study of 
possible interactions and incompatibilities between an active substance and excipients 
used for formulation of particular drug product. 
Qualitative parameters of two drug products were studied. The one product contained 
an antiagregation clopidogrel and the second one contained an antagonist on 
AT1 receptor telmisartan. Analysis was performed based on using FT-IR spectrometry 
(ATR and transmission techniques) and Raman spectrometry after the samples had 
been exposed to the standard and more extreme conditions, particularly high pressure. 
Based on this analysis, there were not observed any changes in qualitative parameters 
for both of active pharmaceutical ingredients. 
 
